Neutrophilic panniculitis in infancy: A cutaneous manifestation of juvenile rheumatoid arthritis - 19/08/11
Doi : 10.1016/j.jaad.2005.11.1101
Jon A. Dyer, MD a, b, d, ⁎ 
, Joan Guitart, MD b, Marisa Klein-Gitelman, MD c, Anthony J. Mancini, MD a, b
, Joan Guitart, MD b, Marisa Klein-Gitelman, MD c, Anthony J. Mancini, MD a, b a Division of Dermatology, Children’s Memorial Hospital, Chicago, Illinois
c Division of Immunology/Rheumatology, Children’s Memorial Hospital, Chicago, Illinois
b Department of Dermatology, Chicago; Northwestern University Feinberg School of Medicine, Chicago, Illinois
d Department of Dermatology, University of Missouri–Columbia, Columbia, Missouri
Reprint requests: Jon A. Dyer, MD, Department of Dermatology, University of Missouri–Columbia, 1 Hospital Dr, Room MA111, Columbia, MO 65212.Abstract |
Neutrophilic panniculitis is rare and is classified as a panniculitic member of the neutrophilic dermatoses spectrum. In affected patients, an underlying systemic disease, such as myelodysplasia, is often present. We describe an infant with juvenile rheumatoid arthritis who developed neutrophilic panniculitis. Neutrophilic panniculitis clinically mimics other panniculitides and biopsy specimen can be diagnostic. Identification of this entity can aid the diagnosis of the underlying systemic process.
Le texte complet de cet article est disponible en PDF.Abbreviations used : EN, G-CSF, JRA, RA
Plan
| Supported by a Dermatology Foundation Fellowship in Pediatric Dermatology (Dr Dyer). |
|
| Conflicts of interest: None declared. |
© 2007
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 57 - N° 5S
P. S65-S68 - novembre 2007 Retour au numéro
Article précédent
- Table of contents
- Reversal of multifocal cutaneous lymphoproliferative disease associated with Epstein-Barr virus after withdrawal of methotrexate therapy for rheumatoid arthritis
- Annabel Maruani, Ewa Wierzbicka, Marie-Christine Machet, Myriam Abdallah-Lotf, Anne de Muret, Laurent Machet
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?